GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...
In 2024, Inogen introduced new products, including Rove 4, and received FDA clearance for the SIMEOX 200 device, expanding its global product offerings. The company maintains a strong financial ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback